Dantrolene aqueous formulation and method for preparing same
JP2020056621A
Method of quantifying liver fatty acid-binding protein, quantification kit for the same, method of testing for renal disease, test kit for the same, and companion diagnostic agent
JP2020056626A
Method of testing for liver disease, test kit for the same, and companion diagnostic agent
WO2020049670A1
Dantrolene aqueous formulation and method for preparing same
TW202010495A
Aqueous product of dantrolene and preparation method thereof having 0.5 mole or more but less than 2 moles of cyclodextrin derivatives relative to 1 mole of dantrolene or a pharmacologically acceptable salt thereof
US2019359663A1
Liver-type fatty acid-binding protein standard, method for evaluating standard, method for regulating variation range of measured value caused by liver-type fatty acid-binding protein in measurement using standard, liver-type fatty acid-binding protein, DNA encoding protein, cell transformed by DNA, method of producing protein, method of drawing calibration curve for liver-type fatty acid-binding protein, and method of quantifying protein
JP2018100256A
Liver-type fatty-acid binding protein marker, evaluation method of marker, method of suppressing fluctuation range of measured value resulting from liver-type fatty acid binding protein measured using marker, method of forming calibration curve of liver-type fatty acid binding protein, and method of quantifying protein
JP2018100230A
Liver-type fatty-acid binding protein marker, evaluation method of marker, method of suppressing fluctuation range of measured value resulting from liver-type fatty acid binding protein measured using marker, method of forming calibration curve of liver-type fatty acid binding protein, and method of quantifying protein
JP2017221155A
Liver type fatty acid binding protein, dna encoding protein, cell transformed with dna, production method of protein, preparation of protein, method of preparing calibration curve of protein, and method of quantifying protein
JP2016214779A
Drainage
WO2015178015A1
Composition for removing color of blood
WO2015045333A1
Myocardial cell proliferation-inducer, pharmaceutical composition containing same, and method for producing myocardial cells
